A recent study supported the accuracy of (18F)Flortaucipir PET visual reads for predicting the presence of AD-like tau pathology at autopsy, suggesting the potential clinical use of (18F)Flortaucipir in the diagnosis of AD [141]. The gene discussed is MAPT; the disease is Alzheimer disease.